Article
First outbreak of VIM-2 metallo-β-lactamase-producing Pseudomonas aeruginosa in The Netherlands: microbiology, epidemiology and clinical outcomes.
International journal of antimicrobial agents - 1 Jun 2011
Van der Bij A K, Van Mansfeld R, Peirano G, Goessens W H F, Severin J A, Pitout J D D, Willems R, Van Westreenen M
Abstract excerpt
This study was designed to investigate the prevalence and characteristics of metallo-β-lactamase (MBL)-producing Pseudomonas aeruginosa in a tertiary care centre in The Netherlands, a country that is considered to have a low prevalence of antibiotic-resistant bacteria. Imipenem-resistant P. aeruginosa isolates cultured from clinical specimens during 2008-2009 were analysed phenotypically and molecularly by...
Topics
Join the communities discussing this publication.
